ADC Therapeutics SA
ADCT
$1.89
$0.2011.83%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.07% | 34.25% | -17.53% | -16.55% | -13.73% |
| Total Depreciation and Amortization | -4.52% | 0.28% | 7.84% | 23.53% | 34.19% |
| Total Amortization of Deferred Charges | -78.06% | -70.09% | -61.85% | -49.21% | -35.61% |
| Total Other Non-Cash Items | -64.48% | -63.27% | 37.64% | -28.31% | -17.35% |
| Change in Net Operating Assets | -1,197.15% | -91.36% | 102.79% | 67.32% | 110.08% |
| Cash from Operations | 7.68% | -4.34% | 5.01% | -42.68% | -23.01% |
| Capital Expenditure | 78.03% | 73.04% | 64.42% | 41.24% | -85.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 78.03% | 73.04% | 6.84% | -99.10% | -970.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13,944.11% | 12,703.10% | 12,697.55% | 1,402.22% | -89.35% |
| Repurchase of Common Stock | -204,100.00% | -204,100.00% | 36.09% | 99.93% | 99.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -100.00% | 2,532.68% |
| Cash from Financing | 31.38% | 31.38% | 38.03% | 35.91% | 34,588.79% |
| Foreign Exchange rate Adjustments | 132.69% | -145.11% | 49.82% | -98.22% | 240.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.09% | 42.04% | 48.71% | -61.92% | 36.62% |